INOVIO PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.57 USD | +4.40% |
|
+9.19% | +72.71% |
Chart calendar Inovio Pharmaceuticals, Inc.
b31a7614.R0NQFSSIbhYPEYH6hrOcnrZ6QL5Mj7bgdTuULkiFVHw.Ly01ZWHGV3xKIOiy9YLs8tEiedF1uveaH1bTR33dNjJyJiJPabAfImJQsQ~60f957a8b1de48fb1e3aed12d2665140
Upcoming events on Inovio Pharmaceuticals, Inc.
Past events on Inovio Pharmaceuticals, Inc.
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - Abstract No:1191 |
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - Abstract No:976 |
| 02/04/2024 07:30 pm | Citizens JMP Novel Therapeutics Forum |
| 07/03/2024 03:00 am | Q4 2023 Earnings Call |
| 07/03/2024 02:35 am | Q4 2023 Earnings Release |
| 14/02/2024 11:10 pm | Oppenheimer Healthcare Life Sciences Conference - Fireside Chat |
| 25/01/2024 | Reverse Split: 1 of 12 |
| 12/01/2024 09:30 pm | Extraordinary Shareholders Meeting |
| 10/11/2023 03:00 am | Q3 2023 Earnings Call |
| 10/11/2023 02:35 am | Q3 2023 Earnings Release |
| 13/09/2023 02:00 am | H.C. Wainwright Global Investment Conference |
| 10/08/2023 02:00 am | Q2 2023 Earnings Call |
| 10/08/2023 01:35 am | Q2 2023 Earnings Release |
| 09/06/2023 05:30 pm | Jefferies Global Healthcare Conference - Fireside Chat |
| 18/05/2023 01:35 am | RBC Global Healthcare Conference |
| 16/05/2023 06:30 pm | Annual General Meeting |
| 11/05/2023 02:00 am | Q1 2023 Earnings Call |
| 11/05/2023 01:35 am | Q1 2023 Earnings Release |
| 05/05/2023 06:30 pm | American Broncho-Esophagological Association Combined Otolaryngology Spring Meeting |
| 16/04/2023 12:00 pm | European of Clinical Microbiology and Infectious Diseases Congress - Abstract No : MMK0202 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,11 5,11 -19.55% | 7,41 3,84 93.02% | 1,77 1,46 21.45% | 10,3 10,6 -2.75% | 0,83 1,07 -22.05% | 0,60 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -298 -258 -15.56% | -263 -245 -7.61% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -111 -104 -6.96% | -124 -131 5.51% | -301 -259 -16.14% | -268 -253 -5.71% | -144 -139 -3.2% | -110 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -121 -107 -13.32% | -163 -179 9.13% | -303 -259 -17.07% | -278 -263 -5.61% | -135 -137 1.22% | -102 |
|
Net income Million USD | Released Forecast Spread | -119 -106 -12.49% | -166 -181 8.13% | -304 -261 -16.33% | -280 -264 -6.02% | -135 -137 1.55% | -99,4 |
|
EPS USD | Released Forecast Spread | -14,5 -12,9 -12.48% | -12,8 -14,1 8.84% | -17,4 -15,2 -14.68% | -14,0 -13,3 -5.6% | -6,09 -5,11 -19.08% | -3,85 |
| Announcement Date | 12/03/20 | 01/03/21 | 01/03/22 | 01/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,84 0,55 52.59% | 0,20 0,66 -69.99% | 0,78 0,52 50.65% | 9,15 0,62 1368.96% | 0,12 0,42 -70.6% | 0,11 0,28 -58.2% | 0,23 0,26 -13.92% | 0,39 0,26 47.98% | 0,10 0,34 -70.17% | 0,15 | 0,15 | 0,15 | 0,15 |
|
EBITDA Million USD | Released Forecast Spread | -104 -64,4 -62.28% | -103 -70,1 -47.05% | -34,7 -70,5 50.72% | -54,9 -37,3 -47.24% | |||||||||
|
EBIT Million USD | Released Forecast Spread | -106 -63,6 -65.93% | -71,7 -74,5 3.67% | -104 -67,0 -55.35% | -35,8 -70,1 49% | -55,9 -41,5 -34.92% | -44,0 -34,4 -27.66% | -37,0 -35,8 -3.61% | -35,6 -34,9 -1.82% | -27,4 -25,0 -9.5% | -27,6 | -27,0 | -27,8 | -27,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -107 -63,1 -69.51% | -79,1 -74,7 -5.82% | -108 -67,3 -61.25% | -37,8 -70,4 46.36% | -54,5 -42,6 -27.9% | -40,6 -38,4 -5.85% | -35,5 -38,1 6.64% | -33,9 -34,3 1.19% | -25,0 -26,1 4.14% | -25,8 | -25,0 | -26,0 | -25,4 |
|
Net income Million USD | Released Forecast Spread | -107 -64,9 -64.9% | -79,1 -74,7 -5.82% | -108 -69,2 -56.88% | -37,8 -71,8 47.4% | -54,5 -41,7 -30.49% | -40,6 -36,7 -10.64% | -35,5 -38,1 6.64% | -33,9 -34,3 1.19% | -25,0 -26,1 4.14% | -24,3 | -23,7 | -24,2 | -23,8 |
|
EPS USD | Released Forecast Spread | -6,00 -3,83 -56.79% | -4,32 -4,12 -4.86% | -5,52 -3,74 -47.59% | -1,80 -3,55 49.27% | -2,64 -2,02 -30.95% | -1,92 -1,74 -10.34% | -1,56 -1,74 10.34% | -1,56 -1,52 -2.63% | -5,67 -1,24 -356.34% | -1,00 | -0,96 | -0,96 | -0,93 |
| Announcement Date | 01/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 01/03/23 | 10/05/23 | 09/08/23 | 09/11/23 | 06/03/24 | - | - | - | - |
More events
Past sector events for Inovio Pharmaceuticals, Inc.
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INO Stock
- Calendar Inovio Pharmaceuticals, Inc.
